J. Kern

B. Davidson, J. Kern, S. Graham, 1998, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Senescence in chronic obstructive pulmonary disease.

Y. Miller, R. Tuder, J. Kern, 2012, Proceedings of the American Thoracic Society.

Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung.

P. Nowell, D. Weiner, A. Gazdar, 1990, Cancer research.

Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease.

M. Cullen, J. Elias, J. Kern, 1988, Annals of internal medicine.

Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb‐B2

R. Govindan, J. Herndon, Mark R. Green, 2005, Cancer.

Dual MET–EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer

Deborah S. Barkauskas, B. Halmos, C. Flask, 2008, British Journal of Cancer.

Lung cancer: new therapeutic targets, new definitions.

J. Kern, J. Finigan, 2012, American journal of respiratory and critical care medicine.

The interactive effect of Ras, HER2, P53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients.

J. Kern, A. Jang, S. Lim, 1998, Lung cancer.

C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.

S. Rodenhuis, D. Weiner, R. Slebos, 1994, The Journal of clinical investigation.

Mechanisms of p185HER2 expression in human non-small cell lung cancer cell lines.

D. Weiner, A. Gazdar, J. Kern, 1992, American journal of respiratory cell and molecular biology.

Aberrant p53 Staining Does Not Predict Cisplatin Resistance in Locally Advanced Non-Small Cell Lung Cancer

D. Klimstra, Mark R. Green, J. Kern, 2002, Cancer investigation.

Sounding the mediastinum.

J. Kern, 2003, American journal of respiratory and critical care medicine.

FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalence.

G. McLennan, B. Mullan, M. W. Peterson, 2002, Lung cancer.

Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms.

P. Nowell, John Calvin Reed, R. Lamb, 1988, The Journal of clinical investigation.

Time-dependent changes in aortic albumin permeability characteristics in experimental diabetes.

J. Kern, T. M. Hollis, N. A. Enea, 1984, Experimental and molecular pathology.

Changes in plasma histamine concentration in the streptozotocin-diabetic rat.

J. Kern, A. Cosgarea, T. M. Hollis, 1985, Experimental and molecular pathology.

endothelial cells production from cultured human pulmonary Endotoxin stimulates platelet-derived growth factor

S. Albelda, J. Elias, J. Kern, 2002 .

Endotoxin stimulates platelet-derived growth factor production from cultured human pulmonary endothelial cells.

S. Albelda, J. Elias, J. Kern, 1989, The American journal of physiology.

NEUREGULIN-1 INDUCES BRANCHING MORPHOGENESIS IN THE DEVELOPING LUNG THROUGH A PI3K SIGNAL PATHWAY

J. Kern, D. Nethery, Jinbo Liu, 2004, Experimental lung research.

Inhibition of human lung cancer cell line growth by an anti-p185HER2 antibody.

D. Weiner, A. Gazdar, H. Shepard, 1993, American journal of respiratory cell and molecular biology.

Inactivation of neuregulin-1 by nitration.

S. Erzurum, J. Kern, Sudakshina Ghosh, 2007, American journal of physiology. Lung cellular and molecular physiology.

CME Part II: Immune checkpoint inhibitor-related dermatologic adverse events.

M. Lacouture, J. Kern, D. Leung, 2020, Journal of the American Academy of Dermatology.

Immune checkpoint inhibitor—related dermatologic adverse events

J. Kern, D. Leung, Lacouture, 2020 .

Interleukin-1-beta gene expression in human monocytes and alveolar macrophages from normal subjects and patients with sarcoidosis.

John Calvin Reed, R. Lamb, J. Elias, 1988, The American review of respiratory disease.

Interleukin‐6 as a Fibroblast‐derived Stimulator

G. Trinchieri, P. Simon, J. Elias, 1989 .

A synergistic interaction of IL-6 and IL-1 mediates the thymocyte-stimulating activity produced by recombinant IL-1-stimulated fibroblasts.

G. Trinchieri, P. Sehgal, P. Simon, 1989, Journal of immunology.

M. Lacouture, J. Kern, D. Leung, 2021, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Regulation of proto-oncogene expression during T lymphocyte activation and proliferation.

P. Nowell, John Calvin Reed, J. Alpers, 1987, Advances in experimental medicine and biology.

Alveolar macrophages, blood monocytes, and density-fractionated alveolar macrophages differ in their ability to promote lymphocyte proliferation to mitogen and antigen.

T. Ferro, J. Elias, J. Kern, 1987, The American review of respiratory disease.

Endogenous human renin expression and promoter activity in CALU-6, a pulmonary carcinoma cell line.

C. Sigmund, G. Yang, J. Kern, 1995, Hypertension.

The 3' untranslated region of IL-1beta regulates protein production.

L. Warnock, J. Kern, J. McCafferty, 1997, Journal of immunology.

Accessory Cells Provide More Than One Signal for Lectin Mitogen‐Stimulated Proliferation of Human Lymphocytes

P. Nowell, J. Kern, R. Daniele, 1985, Journal of leukocyte biology.

Segregation of receptor and ligand regulates activation of epithelial growth factor receptor

M. Welsh, T. Moninger, J. Zabner, 2003, Nature.

Production of interleukin 1 activity by cultured human melanoma cells.

D. Guerry, J. Elias, J. Kern, 1989, Cancer research.

Effect of amplification ofdhfr andlac Z genes on growth and β-galactosidase expression in suspension cultures of recombinant CHO cells

M. Gu, D. Kompala, P. Todd, 1992, Cytotechnology.

Right-to-left anatomic shunt associated with a persistent left superior vena cava: the importance of injection site in demonstrating the shunt.

J. Stoller, F. Jacono, J. Kern, 2009, Chest.

IL 2 alone is mitogenic only for Tac-positive lymphocytes in human peripheral blood.

P. Nowell, J. Kern, D. Taylor, 1986, Journal of immunology.

Role of endotoxin in grain dust-induced lung inflammation in mice.

D. Schwartz, P. Thorne, J. Kern, 1996, The American journal of physiology.

Prognostic Markers in Resected Non–Small-Cell Lung Cancer: An Patients with 5 Year Follow-Up

N. Weidner, J. Kern, S. Mehdi, 1999 .

Application of Solution Equilibrium Analysis to inVitro RNA Transcription

J. Kern, R. Davis, 1997, Biotechnology progress.

Human epidermal growth factor receptor signaling in acute lung injury.

G. Downey, J. Kern, J. Finigan, 2012, American journal of respiratory cell and molecular biology.

Application of a Fed‐Batch System To Produce RNA by In Vitro Transcription

J. Kern, R. Davis, 1999, Biotechnology progress.

Adenovirus-Mediated Gene Therapy for Head and Neck Squamous Cell Carcinomas

B. Davidson, J. Zabner, J. Kern, 1996, The Annals of otology, rhinology, and laryngology.

Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation.

J. Kern, Jinbo Liu, 2002, American journal of respiratory cell and molecular biology.

Our Current Understanding of Checkpoint Inhibitor Therapy in Cancer Immunotherapy.

M. Lacouture, J. Kern, D. Leung, 2021, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Bioinformatics-driven discovery of rational combination for overcoming EGFR-mutant lung cancer resistance to EGFR therapy

Jaewoo Kang, Minjae Yoo, Aik Choon Tan, 2014, Bioinform..

Identification of a human anti-CD55 single-chain Fv by subtractive panning of a phage library using tumor and nontumor cell lines.

P. Carter, J. Ridgway, A. Goddard, 1999, Cancer research.

p185neuExpression in Human Lung Adenocarcinomas Predicts Shortened Survival1

D. Weiner, M. Greene, J. Kern, 2006 .

neuExpression in Human Lung Adenocarcinomas Predicts Shortened Survival 1

D. Weiner, M. Greene, J. Kern, 2006 .

p185neu expression in human lung adenocarcinomas predicts shortened survival.

D. Weiner, M. Greene, J. Kern, 1990, Cancer research.

Contributions of KRAS and RAL in Non–Small-Cell Lung Cancer Growth and Progression

F. Hirsch, D. Theodorescu, M. Wynes, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Role of mTOR as an essential kinase in SCLC.

C. Rudin, Jihye Kim, A. Tan, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Autocrine activation of ErbB2/ErbB3 receptor complex by NRG-1 in non-small cell lung cancer cell lines.

J. Kern, D. Nethery, Jinbo Liu, 2004, Lung cancer.

Evaluation and treatment of patients with non-small cell lung cancer.

J. Kern, L. Carr, J. Finigan, 2011, The Medical clinics of North America.

Activation state EGFR and STAT-3 as prognostic markers in resected non-small cell lung cancer.

R. Eisenberg, P. Fu, A. Dowlati, 2007, Lung cancer.

Disruption of the EGFR E884-R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivity

J. Christensen, T. Boggon, B. Halmos, 2008, Oncogene.

The role of the accessory cell in mitogen-stimulated human T cell gene expression.

P. Nowell, John Calvin Reed, J. Kern, 1986, Journal of immunology.

Resistance to an irreversible epidermal growth factor receptor (EGFR) inhibitor in EGFR-mutant lung cancer reveals novel treatment strategies.

D. Tenen, S. Kobayashi, T. Boggon, 2007, Cancer research.

Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B study.

J. W. Box, J. Herndon, M. Green, 2001, Lung Cancer.

Analysis of neuroendocrine markers, HER2 and CEA before and after chemotherapy in patients with stage IIIA non-small cell lung cancer: a Cancer and Leukemia Group B study.

D. Sugarbaker, J. Herndon, Mark R. Green, 1998, Lung cancer.

Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non–Small Cell Lung Cancer Patients

M. McCarter, S. Singhal, B. Palmer, 2017, Cancer Immunology Research.

Mouse spinal cord compression injury is reduced by either activation of the adenosine A2A receptor on bone marrow–derived cells or deletion of the A2A receptor on non-bone marrow–derived cells

J. Linden, J. Rieger, Y. Li, 2006, Neuroscience.

Histamine H1 receptors mediate increased blood-retinal barrier permeability in experimental diabetes.

T. Gardner, J. Kern, T. M. Hollis, 1989, Archives of ophthalmology.

Neuregulin-1-Human Epidermal Receptor-2 Signaling Is a Central Regulator of Pulmonary Epithelial Permeability and Acute Lung Injury*

M. Matthay, E. Wilkinson, L. Ware, 2011, The Journal of Biological Chemistry.

Neuregulin-1 and human epidermal growth factor receptors 2 and 3 play a role in human lung development in vitro.

M. Sliwkowski, J. Klein, J. M. Snyder, 2000, American journal of respiratory cell and molecular biology.

Beyond steroids: immunosuppressants in steroid-refractory/resistant immune related adverse events.

M. Kris, M. Lacouture, M. Hellmann, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Lung cancer screening: past, present and future.

J. Kern, J. Finigan, 2013, Clinics in chest medicine.

Response to the Methylation Inhibitor Dihydro-5-azacytidine in Mesothelioma Is Not Associated with Methylation of p16INK4a: Results of Cancer and Leukemia Group B 159904

E. Vokes, R. Kratzke, Mark R. Green, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Interleukin-6 is required for Neuregulin-1 induced HER2 signaling in lung epithelium.

J. Kern, J. Finigan, Rangnath Mishra, 2019, Biochemical and biophysical research communications.

Prognostic markers in resected stage I and II non small-cell lung cancer: an analysis of 260 patients with 5 year follow-up.

N. Weidner, J. Kern, S. Mehdi, 1999, Clinical lung cancer.

Combined inhibition of epidermal growth factor receptor and JAK/STAT pathways results in greater growth inhibition in vitro than single agent therapy.

A. Dowlati, J. Kern, Afshin Dowlati, 2004, Molecular cancer therapeutics.

Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761.

G. Patterson, J. Herndon, R. Kratzke, 2002, The Journal of thoracic and cardiovascular surgery.

SCH66336, inhibitor of protein farnesylation, blocks signal transducer and activators of transcription 3 signaling in lung cancer and interacts with a small molecule inhibitor of epidermal growth factor receptor/human epidermal growth factor receptor 2

B. Halmos, A. Dowlati, J. Kern, 2008, Anti-cancer drugs.

Activation state (phosphorylated) EGFR and STAT3 as prognostic markers in resected non-small cell lung cancer (NSCLC)

R. Eisenberg, P. Fu, A. Dowlati, 2005 .

Heat stress regulates the human 70-kDa heat-shock gene through the 3'-untranslated region.

P. Moseley, S. Flanagan, E. Wallen, 1993, The American journal of physiology.

Pathogenesis of sarcoidosis. State of the art.

J. Elias, J. Kern, M. Rossman, 1986, Chest.

Chronic beryllium disease in a precious metal refinery. Clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume.

M R Cullen, J R Kominsky, M. Cherniack, 2015, The American review of respiratory disease.

The Kinome of Human Alveolar Type II and Basal Cells, and its Reprogramming in Lung Cancer.

J. Kern, S. Leach, R. Mason, 2019, American journal of respiratory cell and molecular biology.

Autonomous decision-making: a data mining approach

Andrew Kusiak, Kemp H. Kernstine, Jeffrey A. Kern, 2000, IEEE Transactions on Information Technology in Biomedicine.

Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma

B. Thompson, W. Stanford, J. Amorosa, 1999, Journal of magnetic resonance imaging : JMRI.

HER2-targeted gene transfer.

J. Kern, B. Foster, 1997, Human gene therapy.

Tertiary lymphoid structures target the antitumor immune response to lung cancer.

T. Randall, J. Kern, 2014, American journal of respiratory and critical care medicine.

Nontumor Cell Lines Subtractive Panning of a Phage Library Using Tumor and Identification of a Human Anti-CD 55 Single-Chain Fv by Updated Version

P. Carter, J. Ridgway, A. Goddard, 2000 .

Neuregulin receptor-mediated gene transfer by human epidermal growth factor receptor 2-targeted antibodies and neuregulin-1

M. Sliwkowski, J. Kern, Robert Wakita, 1999, Cancer Gene Therapy.

Immunohistochemical detection of occult lymph node metastases in non-small cell lung cancer: anatomical pathology results from Cancer and Leukemia Group B Trial 9761.

J. Herndon, R. Kratzke, Mark R. Green, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Adverse Events Following Limited Resection versus Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer.

S. Swanson, M. Chidel, C. Slatore, 2022, Annals of the American Thoracic Society.

Bronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammation

T. Standiford, M. Moss, J. Kern, 2012, European Respiratory Journal.

Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non–Small Cell Lung Cancer Patients

M. McCarter, S. Singhal, B. Palmer, 2017, Cancer immunology research.

Title : Antigen-presenting intratumoral B cells affect CD 4 + TIL phenotypes in non-small cell lung cancer patients

M. McCarter, S. Singhal, B. Palmer, 2017 .

Human epidermal growth factor receptor signaling in acute lung injury.

G. Downey, J. Kern, J. Finigan, 2012, American journal of respiratory cell and molecular biology.

HER2-Neuregulin Mediated IL-8 Release In Cystic Fibrosis

M. Konstan, J. Kern, T. Bonfield, 2011, ATS 2011.

Role of Smad2/3 and p38 MAP kinase in TGF‐β1‐induced epithelial–mesenchymal transition of pulmonary epithelial cells

J. Kern, D. Nethery, I. Kolosova, 2011, Journal of cellular physiology.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.

Development of a Cancer Care Summary Through the Electronic Health Record.

J. Kern, P. Zelarney, L. Carr, 2016, Journal of oncology practice.

HER2 activation results in β-catenin-dependent changes in pulmonary epithelial permeability.

J. Kern, J. Thaikoottathil, R. Mason, 2015, American journal of physiology. Lung cellular and molecular physiology.

Oncogenes and growth factors in human lung cancer.

J. Kern, A. Filderman, 1993, Clinics in chest medicine.